Skip to main content
CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST

CNBX Pharmaceuticals Revenue

CNBX Pharmaceuticals had revenue of $40.64K in the twelve months ending November 30, 2024, down -91.87% year-over-year. In the fiscal year ending August 31, 2024, CNBX Pharmaceuticals had annual revenue of $130.07K, down -68.29%.

Revenue (ttm)
40.64K
Revenue Growth
-91.87%
P/S Ratio
6.89
Revenue / Employee
20.32K
Employees
2
Market Cap
280.00K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2024130.07K-280.09K-68.29%
Aug 31, 2023410.17K380.21K1,269.13%
Aug 31, 202229.96K--
Aug 31, 2021---
Aug 31, 20207.16K-2.69K-27.29%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.79B
Veradigm 1.53B
SS Innovations International 16.04M
Elite Pharmaceuticals 71.17M
Glass House Brands 188.29M
Northwest Biotherapeutics 1.60M
BioStem Technologies 210.49M
Silence Therapeutics 21.77M
Revenue Rankings

CNBX Pharmaceuticals News

More News